The structural and functional consequences of chronic allergic inflammation of the airways.

Although asthma is generally considered a form of reversible airway obstruction, there is evidence that chronic allergic inflammation can lead to structural changes in the airway and a degree of progressive fixed airway obstruction. More importantly, these structural changes can lead to airway hyper-responsiveness. The structural consequences of chronic allergic inflammation are secondary to cellular proliferation and reorganization of the connective tissue constituents of the airway wall. Smooth muscle proliferation and hypertrophy may increase the potential for smooth muscle shortening against the elastic loads provided by lung parenchymal recoil and airway mucosal folding. Resident airway cells, as well as inflammatory cells, produce mediators, cytokines and growth factors that stimulate production of connective tissue proteins and proteoglycans that cause airway remodelling and altered mechanical function. Thickening of the airway wall internal to the smooth muscle layer can amplify the effect of smooth muscle shortening on airway calibre, and it could also stiffen the airway making it less distensible. Thickening of the airway wall external to the muscle can uncouple the airway from the distending force applied by the lung parenchyma. Early and aggressive anti-inflammatory medication may alter the natural history of asthma by preventing the structural changes that are a consequence of chronic allergic inflammation.

[1]  P. Howarth,et al.  Urinary glycosaminoglycan levels are increased in acute severe asthma--a role for eosinophil-derived gelatinase B? , 1997, International archives of allergy and immunology.

[2]  R. Thomson,et al.  Airway muscle stereology: implications for increased shortening in asthma. , 1996, American journal of respiratory and critical care medicine.

[3]  E. Hessel,et al.  Lung inflammation and epithelial changes in a murine model of atopic asthma. , 1996, American journal of respiratory cell and molecular biology.

[4]  M. Jordana,et al.  Eosinophils as a potential source of platelet-derived growth factor B-chain (PDGF-B) in nasal polyposis and bronchial asthma. , 1995, American journal of respiratory cell and molecular biology.

[5]  M. Yacoub,et al.  Insulin-like growth factor I is a major fibroblast mitogen produced by primary cultures of human airway epithelial cells. , 1995, Clinical science.

[6]  R. Schellenberg,et al.  Collagenase increases shortening of human bronchial smooth muscle in vitro. , 1995, American journal of respiratory and critical care medicine.

[7]  S. Weiss,et al.  A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary-function decline: the Normative Aging Study. , 1995, American journal of respiratory and critical care medicine.

[8]  V. Kinnula,et al.  Modulation of fibronectin and tenascin production in human bronchial epithelial cells by inflammatory cytokines in vitro. , 1995, American journal of respiratory cell and molecular biology.

[9]  J. Hogg,et al.  Cartilaginous airway dimensions and airflow obstruction in human lungs. , 1995, American journal of respiratory and critical care medicine.

[10]  B. Rosner,et al.  Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1. , 1995, American journal of respiratory and critical care medicine.

[11]  S. Holgate,et al.  The influence of increased bronchial responsiveness, atopy, and serum IgE on decline in FEV1. A longitudinal study in the elderly. , 1995, American journal of respiratory and critical care medicine.

[12]  C. Roberts,et al.  Is asthma a fibrotic disease? , 1995, Chest.

[13]  L. Fabbri,et al.  Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects. , 1995, American journal of respiratory and critical care medicine.

[14]  J. Solway,et al.  Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats. , 1995, American journal of respiratory and critical care medicine.

[15]  L. Laitinen,et al.  Modulation of bronchial inflammation: corticosteroids and other therapeutic agents. , 1994, American journal of respiratory and critical care medicine.

[16]  L. Paquette,et al.  Airway inflammation after removal from the causal agent in occupational asthma due to high and low molecular weight agents. , 1994, The European respiratory journal.

[17]  J. Hogg,et al.  Proposed nomenclature for quantifying subdivisions of the bronchial wall. , 1994, Journal of applied physiology.

[18]  R. Hegele,et al.  Persistence of respiratory syncytial virus genome and protein after acute bronchiolitis in guinea pigs. , 1994, Chest.

[19]  P. Paré,et al.  Chronic fenoterol exposure increases in vivo and in vitro airway responses in guinea pigs. , 1994, American journal of respiratory and critical care medicine.

[20]  J. Hogg,et al.  Transforming growth factor beta 1 gene expression in human airways. , 1994, Thorax.

[21]  R. Schellenberg,et al.  Hypothesis: excessive bronchoconstriction in asthma is due to decreased airway elastance. , 1994, The European respiratory journal.

[22]  M. Mulvany Resistance vessel structure and the pathogenesis of hypertension , 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[23]  P. Paré,et al.  Small airways dimensions in asthma and in chronic obstructive pulmonary disease. , 1993, The American review of respiratory disease.

[24]  D. Danielpour,et al.  Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. , 1993, The Journal of clinical investigation.

[25]  J. Wilson,et al.  The lack of distensibility of asthmatic airways. , 1993, The American review of respiratory disease.

[26]  M. Ebina,et al.  Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. , 1993, The American review of respiratory disease.

[27]  R. Reed,et al.  Increased negativity of interstitial fluid pressure in rat trachea after mast cell degranulation. , 1993, Journal of applied physiology.

[28]  A. James,et al.  The structure of large and small airways in nonfatal and fatal asthma. , 1993, The American review of respiratory disease.

[29]  M. Chan-yeung,et al.  Methacholine responsiveness, smoking, and atopy as risk factors for accelerated FEV1 decline in male working populations. , 1992, The American review of respiratory disease.

[30]  D. Romberger,et al.  Modulation of fibronectin production of bovine bronchial epithelial cells by transforming growth factor-beta. , 1992, American journal of respiratory cell and molecular biology.

[31]  P. Paré,et al.  A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.

[32]  P. Paré,et al.  In vivo loads on airway smooth muscle: the role of noncontractile airway structures. , 1992, Canadian journal of physiology and pharmacology.

[33]  Y. Deguchi Spontaneous increase of transforming growth factor beta production by bronchoalveolar mononuclear cells of patients with systemic autoimmune diseases affecting the lung. , 1992, Annals of the rheumatic diseases.

[34]  J. Bousquet,et al.  Asthma: a disease remodeling the airways , 1992, Allergy.

[35]  S. Sapienza,et al.  Structural changes in the airways of sensitized brown Norway rats after antigen challenge. , 1991, The American review of respiratory disease.

[36]  A. Barrett,et al.  Human sputum cathepsin B degrades proteoglycan, is inhibited by alpha 2-macroglobulin and is modulated by neutrophil elastase cleavage of cathepsin B precursor and cystatin C. , 1991, The Biochemical journal.

[37]  P. Howarth,et al.  Myofibroblasts and subepithelial fibrosis in bronchial asthma. , 1990, American journal of respiratory cell and molecular biology.

[38]  P. Paré,et al.  Small airway dimensions in smokers with obstruction to airflow. , 1990, The American review of respiratory disease.

[39]  M. Tanemura,et al.  Hyperreactive site in the airway tree of asthmatic patients revealed by thickening of bronchial muscles. A morphometric study. , 1990, The American review of respiratory disease.

[40]  T. Bai,et al.  Abnormalities in airway smooth muscle in fatal asthma. , 1990, The American review of respiratory disease.

[41]  S. Holgate,et al.  SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS , 1989, The Lancet.

[42]  P. Paré,et al.  The mechanics of airway narrowing in asthma. , 1989, The American review of respiratory disease.

[43]  J. Hogg,et al.  The use of the internal perimeter to compare airway size and to calculate smooth muscle shortening. , 1988, The American review of respiratory disease.

[44]  P. Paré,et al.  Effects of lung volume, bronchoconstriction, and cigarette smoke on morphometric airway dimensions. , 1988, Journal of applied physiology.

[45]  J. N. Evans,et al.  Mechanical properties and structure of isolated pulmonary arteries remodeled by chronic hyperoxia. , 1987, The American review of respiratory disease.

[46]  K. Kivirikko,et al.  Synthesis and degradation of type I procollagen mRNAs in cultured human skin fibroblasts and the effect of cortisol. , 1985, The Journal of biological chemistry.

[47]  G. Turino,et al.  Glycosaminoglycan Synthesis in Endotoxin-Induced Lung Injury , 1983, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[48]  B. Heard,et al.  Hyperplasia of bronchial muscle in asthma , 1973 .

[49]  J. Anderson,et al.  A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema , 1969, Thorax.

[50]  J. Trounce,et al.  A Clinical and Pathological Study of Fatal Cases of Status Asthmaticus , 1953, Thorax.

[51]  K. Koessler,et al.  THE PATHOLOGY OF BRONCHIAL ASTHMA , 1922 .